Botanical Identity Testing for Dietary Supplements: Why DNA Barcoding Has Become a Practical Necessity

A 2013 study published in BMC Medicine tested 44 herbal supplement products from 12 companies and found that 59% contained species substitution, contamination with undeclared plants, or both. Some bottles labeled as St. John’s Wort contained Senna alexandrina — a laxative. One ginkgo product showed DNA from black walnut, a common allergen with serious implications for sensitive consumers. The researchers weren’t looking at fly-by-night operations; these were commercially available products from recognizable brands.

That study is over a decade old now. Supply chains have evolved, regulatory pressure has increased, and testing methods have improved. But the botanical identity problem hasn’t gone away — if anything, the sourcing intermediary count has grown, adding more handoff points where species identity can quietly drift from what’s on the label to whatever is most available and cheapest that week.

The Identity Gap Hidden in Your Ingredient Supply Chain

The core issue is straightforward: a supplier’s certificate of analysis (COA) tells you what someone downstream in the supply chain claims is in the material. It doesn’t independently verify botanical species identity. Most COA testing for botanical raw materials covers appearance, odor, loss on drying, and occasionally a basic microscopy check. None of that reliably distinguishes Panax ginseng from Eleutherococcus senticosus — two plants that look identical as a ground powder and sell at meaningfully different price points.

The substitution isn’t always deliberate fraud. A farmer in one region applies the common name used for a more expensive species to a local cultivar. An exporter doesn’t investigate closely enough. By the time the material clears U.S. customs and arrives at a domestic warehouse, five parties have touched the paperwork and the original botanical identity has never been independently verified at the molecular level.

Under 21 CFR Part 111 — the Current Good Manufacturing Practice regulation for dietary supplements, finalized in 2007 — manufacturers are required to verify the identity of each component before use, not simply rely on supplier documentation. Specifically, 21 CFR §111.75(a)(1)(i) requires that you conduct at least one appropriate test or examination to verify the identity of each incoming component. A supplier COA is a supporting document. It is not a substitute for that test.

And yet, at our supplement testing lab we still regularly see companies submitting finished products for potency or heavy metals testing while assuming on faith that the botanical ingredients are what they think they are. That assumption is a Form 483 observation waiting to happen.

How DNA Barcoding Catches What Traditional Testing Misses

DNA barcoding works by sequencing short, standardized gene regions from a plant sample and matching the resulting sequence against a curated reference database of known species. For botanical raw materials, the two most widely used target regions are rbcL (a chloroplast gene encoding a key enzyme in carbon fixation) and matK (a chloroplast gene encoding maturase K). The ITS2 internal transcribed spacer region is also commonly used when finer taxonomic resolution is needed — for instance, distinguishing between closely related species within the Echinacea genus.

The strength of this approach is its objectivity. Every plant species leaves a molecular signature that can’t be mimicked by grinding the wrong plant into the right color powder. A sample that looks, smells, and passes organoleptic inspection as Hydrastis canadensis (goldenseal) will still fail a DNA barcoding test if it’s actually Coptis japonica — a cheaper plant sometimes substituted because both contain berberine and produce a visually similar yellow powder.

USP <563>, Identification of Botanical Raw Materials Using a DNA Sequencing Method, formalizes this approach for supplement testing. The chapter outlines validated DNA extraction protocols, PCR amplification conditions, and sequencing parameters. Notably, USP <563> is performance-based — it defines what acceptable identification looks like rather than mandating a single rigid protocol. That flexibility is intentional, because the extraction chemistry that works for a dried leaf doesn’t necessarily work for a dense root powder or a spray-dried botanical concentrate.

For an ISO 17025 accredited supplement testing lab, turnaround on DNA barcoding runs approximately 3 to 5 business days, depending on matrix complexity and whether confirmatory sequencing is needed. That’s fast enough to fit comfortably into most incoming raw material workflows without disrupting production schedules.

Navigating USP <563> and 21 CFR Part 111 Together

The question we hear most from manufacturers: does running DNA barcoding actually satisfy 21 CFR §111.75 for botanical identity? The short answer is yes — with one important caveat.

DNA barcoding performed under USP <563> guidance is scientifically rigorous and FDA-defensible as an “appropriate test or examination.” But the regulation also requires you to document your testing specifications in advance. That means defining, in writing, which species and which marker regions you’re testing against, what your sequence identity acceptance threshold is, and what your out-of-specification procedure looks like when a result is inconclusive or shows an unexpected match.

If you’re testing Echinacea purpurea raw material, your specification should require that rbcL and matK sequences match E. purpurea reference sequences with at least ≥97% similarity — and that material matching Echinacea angustifolia, a related species with a meaningfully different phytochemical profile and clinical evidence base, is flagged for review rather than automatically released. That specificity is what turns a sequencing result into a controlled quality decision.

We recommend building botanical identity specifications into your raw material testing protocols for every herbal ingredient in your product portfolio, not just the expensive or high-profile ones. FDA warning letters from recent years have made clear that “I relied on my supplier’s COA” is not an adequate corrective action response to an identity failure found during an inspection.

The Real Limitations You Need to Know Before Building Your Program

DNA barcoding isn’t a universal solution, and any supplement testing lab that presents it as one is overselling the method. Two limitations matter practically.

Highly processed extracts are the hard case. DNA is degraded by heat, pH extremes, and the enzymatic activity that occurs during extraction. A standardized turmeric extract that’s been through solvent extraction, filtration, spray drying, and encapsulation may contain very little intact, amplifiable DNA. In these situations, a sample can fail to produce a usable PCR product not because the species identity is wrong but because there simply isn’t enough intact template. For materials where DNA recovery is expected to be low, HPTLC (high-performance thin-layer chromatography) or chemical marker profiling by HPLC should serve as your primary or backup identification method.

Multi-ingredient blends require separate handling. A proprietary herbal formula with six botanical components is difficult to characterize by DNA barcoding because each species’ DNA competes during PCR amplification. The dominant species typically produces a clean result; low-abundance species are often masked. For blend identity testing, microscopy and HPTLC generally provide better coverage across all components.

There’s a third issue that doesn’t get enough attention in lab discussions: reference database quality. DNA barcoding is only as reliable as the database you’re matching against. NCBI GenBank is large and publicly accessible, but it contains errors — misidentified sequences that have propagated through the literature for years. Working with a lab that maintains internally curated and verified reference databases for commonly tested botanical species is worth asking about when you’re qualifying a testing partner.

What a Defensible Botanical Identity Program Actually Looks Like

Putting it all together, a compliant and scientifically defensible botanical identity program has four operational components.

First, a species-specific testing specification for each botanical raw material, incorporated into your supplier qualification documentation and raw material specifications — not a generic “perform identity test” placeholder.

Second, a primary identification method — DNA barcoding under USP <563> guidance, performed by an ISO 17025 accredited supplement testing lab — applied to each incoming lot before the material is cleared for use.

Third, a validated secondary method for matrices where DNA recovery is expected to be poor: HPTLC, chemical marker HPLC, or macro/microscopic examination, depending on the form factor of the ingredient.

Fourth, a lot-release gate that requires a passing identity result before material enters production. Not a retroactive corrective action review — a gate. The distinction matters for both your GMP compliance status and your product liability exposure.

The cost of DNA barcoding at a qualified lab typically runs $150 to $300 per sample for standard botanical raw materials. Set against the cost of an FDA warning letter, a voluntary recall, or a consumer adverse event involving an undisclosed allergen, the math is not complicated.

The 2013 BMC Medicine study found what it found not because botanical fraud is uniquely pervasive, but because identity verification was — and in far too many companies, still is — treated as a paperwork exercise rather than a scientific one. The validated methods to do it properly are commercially accessible and faster than ever. The regulatory obligation has been on the books since 2007. There’s less justification than ever to keep leaving this gap open.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• 21 CFR Part 111 Audit Preparation for Supplement Manufacturers — Aurora TIC covers FDA regulatory consulting, including GMP audit readiness and corrective action programs for dietary supplement companies.
• Raw Material Supplier Qualification and COA Verification — Ayah Labs specializes in global B2B raw material identity and purity testing to support supplier qualification programs.
• Natural Health Product Ingredient Testing Under Canadian Regulations — Androxa covers botanical compliance testing under Health Canada’s Natural Health Products Regulations for brands selling in Canada.